B
BioCryst Pharmaceuticals, Inc. (BCRX)
NMS – Real vaqt narxi. Valyuta: USD
9.94
+0.04 (0.40%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
9.95
+0.01 (0.12%)
Bozordan keyin: Jun 26, 2026, 7:18 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
9.94
+0.04 (0.40%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
9.95
+0.01 (0.12%)
Bozordan keyin: Jun 26, 2026, 7:18 PM EDT
This stock has a consensus price target of $20.07 based on the ratings of 15 analysts. The high is $32.00 and the low is $9.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 9 | $ 20.07 | $ 32 |
| O’zgarish | -9.09% | 102.73% | 223.23% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-05-07 | 181.69% | Citizens | $25 → $28 | Maintains | Market Outperform |
| 2026-05-07 | 111.27% | Wedbush | $22 → $21 | Maintains | Outperform |
| 2026-05-06 | 60.97% | Needham | $18 → $16 | Maintains | Buy |
| 2026-01-30 | 30.78% | RBC Capital | $14 → $13 | Maintains | Outperform |
| 2025-12-15 | 221.93% | HC Wainwright & Co. | $30 → $32 | Maintains | Buy |